IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., the developer of the first rechargeable Sacral Neuromodulation (r-SNM™) System for the treatment of urinary and fecal ...

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...

Ladies and gentlemen, thank you for standing by and welcome to the Axonics Q3 2019 Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation ...

Fintel reports that on April 14, 2023, Mizuho initiated coverage of Axonics Modulation Technologies (NASDAQ:AXNX) with a Buy recommendation. As of April 6, 2023, the average one-year price target for ...

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral ...

* AXONICS MODULATION TECHNOLOGIES INC - MOST EMPLOYEES WILL BE TAKING TEMPORARY 20% CUT IN BASE SALARY FOR REMAINDER OF Q2 2020 DUE TO COVID-19 IMPACT Sign up here. * AXONICS MODULATION TECHNOLOGIES - ...

As of March 24, 2023, the average one-year price target for Axonics Modulation Technologies is $84.09. The forecasts range from a low of $65.65 to a high of $94.50. The average price target represents ...

Axonics Modulation Technologies (AXNX – Research Report) received a Hold rating and price target from Wolfe Research analyst Michael Polark yesterday. The company’s shares closed yesterday at $69.36.

Welcome to the Axonics Q4 2020 Results Call. My name is Richard, and I'll be your operator for today's call. [Operator Instructions] I will now turn the call over to Neil Bhalodkar. You may begin.